| Product Code: ETC7200010 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
In 2024, Finland saw significant shifts in the isoxazoline import market, with top exporting countries being the Netherlands, Czechia, China, India, and Metropolitan France. Despite a decrease in the concentration level compared to 2023, the market remained highly concentrated in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 was -0.74%, indicating a slight decline in the market over the period. Moreover, the growth rate from 2023 to 2024 was notably negative at -16.58%, suggesting a challenging year for isoxazoline imports in Finland.
| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 Finland Isoxazoline Market Overview | 
| 3.1 Finland Country Macro Economic Indicators | 
| 3.2 Finland Isoxazoline Market Revenues & Volume, 2021 & 2031F | 
| 3.3 Finland Isoxazoline Market - Industry Life Cycle | 
| 3.4 Finland Isoxazoline Market - Porter's Five Forces | 
| 3.5 Finland Isoxazoline Market Revenues & Volume Share, By Product Type, 2021 & 2031F | 
| 3.6 Finland Isoxazoline Market Revenues & Volume Share, By Pet Type, 2021 & 2031F | 
| 4 Finland Isoxazoline Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.2.1 Increasing prevalence of flea and tick-borne diseases in pets leading to higher demand for isoxazoline products. | 
| 4.2.2 Growing pet ownership rates in Finland, driving the need for effective parasite control solutions. | 
| 4.2.3 Innovation and development of newer isoxazoline formulations with improved efficacy and safety profiles. | 
| 4.3 Market Restraints | 
| 4.3.1 Stringent regulations governing the use of veterinary products, potentially limiting market entry for new isoxazoline products. | 
| 4.3.2 Potential adverse effects associated with isoxazoline products leading to safety concerns among pet owners. | 
| 4.3.3 Competition from alternative parasite control products such as spot-on treatments and collars. | 
| 5 Finland Isoxazoline Market Trends | 
| 6 Finland Isoxazoline Market, By Types | 
| 6.1 Finland Isoxazoline Market, By Product Type | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 Finland Isoxazoline Market Revenues & Volume, By Product Type, 2021- 2031F | 
| 6.1.3 Finland Isoxazoline Market Revenues & Volume, By Fluralaner, 2021- 2031F | 
| 6.1.4 Finland Isoxazoline Market Revenues & Volume, By Afoxolaner, 2021- 2031F | 
| 6.1.5 Finland Isoxazoline Market Revenues & Volume, By Sarolaner, 2021- 2031F | 
| 6.1.6 Finland Isoxazoline Market Revenues & Volume, By Lotilaner, 2021- 2031F | 
| 6.2 Finland Isoxazoline Market, By Pet Type | 
| 6.2.1 Overview and Analysis | 
| 6.2.2 Finland Isoxazoline Market Revenues & Volume, By Dog, 2021- 2031F | 
| 6.2.3 Finland Isoxazoline Market Revenues & Volume, By Cat, 2021- 2031F | 
| 7 Finland Isoxazoline Market Import-Export Trade Statistics | 
| 7.1 Finland Isoxazoline Market Export to Major Countries | 
| 7.2 Finland Isoxazoline Market Imports from Major Countries | 
| 8 Finland Isoxazoline Market Key Performance Indicators | 
| 8.1 Number of new isoxazoline product launches in the Finnish market. | 
| 8.2 Adoption rate of isoxazoline products among veterinarians and pet owners. | 
| 8.3 Rate of compliance with treatment protocols among pet owners using isoxazoline products. | 
| 9 Finland Isoxazoline Market - Opportunity Assessment | 
| 9.1 Finland Isoxazoline Market Opportunity Assessment, By Product Type, 2021 & 2031F | 
| 9.2 Finland Isoxazoline Market Opportunity Assessment, By Pet Type, 2021 & 2031F | 
| 10 Finland Isoxazoline Market - Competitive Landscape | 
| 10.1 Finland Isoxazoline Market Revenue Share, By Companies, 2024 | 
| 10.2 Finland Isoxazoline Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |